{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:43:40Z","timestamp":1791031420975,"version":"4.1.0"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:p>BACKGROUND. Bloodstream infections with Candida species have a high mortality rate in very low birth weight infants. Preliminary data suggest that prophylaxis with fluconazole reduces the incidence of colonization and invasive Candida infections in high-risk, very low birth weight neonates. The extent of antifungal prophylaxis use to prevent neonatal candidemia is unknown.<\/jats:p>\n               <jats:p>METHODS. We surveyed a 20% random sample of the members of the American Academy of Pediatrics Section on Perinatal Pediatrics. We collected information on prophylactic agents used, indications for use, and rationale for reported practices.<\/jats:p>\n               <jats:p>RESULTS. A total of 219 (47%) of 469 members sampled responded; 3 clinicians who did not provide care to very low birth weight infants were excluded. Antifungal prophylaxis use was reported by 73 (34%) respondents. Agents used included intravenous fluconazole (66%), oral nystatin (59%), and intravenous amphotericin B (21%). Decreased birth weight or early gestational age was the most frequent indication to start prophylaxis (57 [78%]). Respondents who did not use antifungal prophylaxis compared with respondents who used fluconazole prophylaxis were significantly more likely to have concerns about (1) the emergence of antifungal resistance, (2) unclear criteria on which to base the decision to start prophylaxis, and (3) the need for clarification of the role of surveillance cultures.<\/jats:p>\n               <jats:p>CONCLUSIONS. Although preliminary data suggest that fluconazole is efficacious to prevent candidemia in a subset of neonates, this practice is not used widely by clinicians who care for very low birth weight infants. Additional efficacy studies should address the emergence of antifungal resistance or clarification of criteria to initiate prophylaxis, including the role of surveillance cultures.<\/jats:p>","DOI":"10.1542\/peds.2006-0446","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T00:43:06Z","timestamp":1158626586000},"page":"e1019-e1026","source":"Crossref","is-referenced-by-count":58,"title":["Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices"],"prefix":"10.1542","volume":"118","author":[{"given":"Lauren A.","family":"Burwell","sequence":"first","affiliation":[{"name":"Office of Workforce and Career Development"},{"name":"Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Blakely","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Stoll","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Fridkin","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,10,1]]},"reference":[{"key":"2021120822423462400_R1","doi-asserted-by":"crossref","unstructured":"Stoll B, Hansen N, Fanaroff A, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics.\u20082002;110:285\u2013291","DOI":"10.1542\/peds.110.2.285"},{"key":"2021120822423462400_R2","doi-asserted-by":"crossref","unstructured":"Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics.\u20082006;117:84\u201392","DOI":"10.1542\/peds.2004-2292"},{"key":"2021120822423462400_R3","doi-asserted-by":"crossref","unstructured":"Saiman L, Ludington E, Pfaller M. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J.\u20082000;19:319\u2013324","DOI":"10.1097\/00006454-200004000-00011"},{"key":"2021120822423462400_R4","doi-asserted-by":"crossref","unstructured":"Lopez Sastre J, Coto Cotallo G, Fernandez Colomer B. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol.\u20082003;20:153\u2013163","DOI":"10.1055\/s-2003-40008"},{"key":"2021120822423462400_R5","doi-asserted-by":"crossref","unstructured":"Shetty SS, Harrison LH, Hajjeh RA, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998\u20132000. Pediatr Infect Dis J.\u20082005;24:601\u2013604","DOI":"10.1097\/01.inf.0000168751.11375.d6"},{"key":"2021120822423462400_R6","doi-asserted-by":"crossref","unstructured":"Warris A, Semmekrot B, Voss A. Candidal and bacterial bloodstream infections in premature neonates: a case-control study. Med Mycol.\u20082001;39:75\u201379","DOI":"10.1080\/mmy.39.1.75.79"},{"key":"2021120822423462400_R7","doi-asserted-by":"crossref","unstructured":"Weese-Mayer D, Fondreist D, Brouillette R. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J.\u20081987;6:190\u2013196","DOI":"10.1097\/00006454-198702000-00009"},{"key":"2021120822423462400_R8","doi-asserted-by":"crossref","unstructured":"Rowen JL, Rench MA, Kozinetz CA, Adams JM Jr, Baker CJ. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr.\u20081994;124:789\u2013794","DOI":"10.1016\/S0022-3476(05)81375-7"},{"key":"2021120822423462400_R9","doi-asserted-by":"crossref","unstructured":"Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics.\u20082001;107:293\u2013298","DOI":"10.1542\/peds.107.2.293"},{"key":"2021120822423462400_R10","doi-asserted-by":"crossref","unstructured":"Kaufman D, Boyle R, Hazen K. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med.\u20082001;345:1660\u20131666","DOI":"10.1056\/NEJMoa010494"},{"key":"2021120822423462400_R11","unstructured":"Bradley JS, Nelson JD. Nelson's Pocket Book of Pediatric Antimicrobial Therapy. 15th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002"},{"key":"2021120822423462400_R12","doi-asserted-by":"crossref","unstructured":"Abi-Said D, Anaissie E, Uzon O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis.\u20081997;24:1122\u20131128","DOI":"10.1086\/513663"},{"key":"2021120822423462400_R13","doi-asserted-by":"crossref","unstructured":"Abbas J, Bodey GP, Hanna HA, et al. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med.\u20082000;160:2659\u20132664","DOI":"10.1001\/archinte.160.17.2659"},{"key":"2021120822423462400_R14","doi-asserted-by":"crossref","unstructured":"Bodey GP, Mardani M, Hanna HA, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med.\u20082002;112:380\u2013385","DOI":"10.1016\/S0002-9343(01)01130-5"},{"key":"2021120822423462400_R15","doi-asserted-by":"crossref","unstructured":"Ostrosky-Zeichner L, Rex JH, Pappas PG, et al. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother.\u20082003;47:3149\u20133154","DOI":"10.1128\/AAC.47.10.3149-3154.2003"},{"key":"2021120822423462400_R16","doi-asserted-by":"crossref","unstructured":"Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis.\u20082000;181:309\u2013316","DOI":"10.1086\/315193"},{"key":"2021120822423462400_R17","doi-asserted-by":"crossref","unstructured":"Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of &lt;1000 grams birth weight. J Pediatr.\u20082005;147:172\u2013179","DOI":"10.1016\/j.jpeds.2005.03.036"},{"key":"2021120822423462400_R18","doi-asserted-by":"crossref","unstructured":"Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis.\u20081992;14:495\u2013491","DOI":"10.1093\/clinids\/14.2.485"},{"key":"2021120822423462400_R19","doi-asserted-by":"crossref","unstructured":"Weitkamp JH, Poets CF, Sievers R, et al. Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). Infection.\u20081998;26:11\u201315","DOI":"10.1007\/BF02768745"},{"key":"2021120822423462400_R20","doi-asserted-by":"crossref","unstructured":"El-Masry F, Neal T, Subhedar N. Risk factors for invasive fungal infection in neonates. Acta Paediatr.\u20082002;91:198\u2013202","DOI":"10.1111\/j.1651-2227.2002.tb01695.x"},{"key":"2021120822423462400_R21","doi-asserted-by":"crossref","unstructured":"Sims ME, Yoo Y, You H, Salminen C, Walther FJ. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol.\u20081988;5:33\u201336","DOI":"10.1055\/s-2007-999649"},{"key":"2021120822423462400_R22","doi-asserted-by":"crossref","unstructured":"Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr.\u20082005;147:166\u2013171","DOI":"10.1016\/j.jpeds.2005.04.016"},{"key":"2021120822423462400_R23","doi-asserted-by":"crossref","unstructured":"Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr.\u20082005;147:162\u2013165","DOI":"10.1016\/j.jpeds.2005.02.020"},{"key":"2021120822423462400_R24","doi-asserted-by":"crossref","unstructured":"Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics.\u20082006;117(1). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/1\/e22","DOI":"10.1542\/peds.2004-2227"},{"key":"2021120822423462400_R25","doi-asserted-by":"crossref","unstructured":"Uko S, Soghier LM, Vega M, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics. 2006;117:1243\u20131252","DOI":"10.1542\/peds.2005-1969"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/e1019\/1116737\/zpe010060e1019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/e1019\/1116737\/zpe010060e1019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T02:31:52Z","timestamp":1639017112000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/4\/e1019\/69046\/Antifungal-Prophylaxis-to-Prevent-Neonatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,10,1]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0446","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}